Literature DB >> 26713749

How reliable is the Ki-67 cytological index in grading pancreatic neuroendocrine tumors? A meta-analysis.

Jun Li1,2, Jin Ping Lin1,2, Liu Hong Shi3, Wei Jia Wang4, Ai Qing Li1,2, Jian Min Si1,2, Shu Jie Chen1,2.   

Abstract

OBJECTIVE: To investigate the accuracy of the cytological Ki-67 index in distinguishing intermediate and high-grade (G2 + G3) from low-grade (G1) pancreatic neuroendocrine tumors (PNETs).
METHODS: Two investigators independently searched databases to identify eligible studies using the following term: ('Ki-67') AND ('pancreatic endocrine tumor' OR 'pancreatic neuroendocrine tumor' OR 'pancreatic endocrine tumour' OR 'pancreatic neuroendocrine tumour' OR 'pancreatic endocrine tumors' OR 'pancreatic neuroendocrine tumors' OR 'pancreatic endocrine tumours' OR 'pancreatic neuroendocrine tumours'), and meta-analysis was performed to calculate the pooled sensitivity, specificity, positive (PLR) and negative likelihood ratio (NLR), and diagnostic odds ratio (DOR).
RESULTS: A total of 263 lesions from 13 studies were included in the study. The pooled sensitivity and specificity of Ki-67 (cut-off value: 2%) in the differential diagnosis of G2 + G3 from G1 PNETs were 64% and 87%, respectively. The pooled PLR, NLR and DOR were 3.96, 0.42 and 11.21, respectively. The area under the summary receiver operating characteristic curve (AUROC) was 0.8397. While the cut-off value of Ki-67 index was set as 5%, the sensitivity and specificity were increased up to 69% and 93%, respectively, and the AUROC was increased to 0.955.
CONCLUSION: The cytological Ki-67 index is very useful in distinguishing intermediate and high-grade from low-grade PNETs, and a cut-off value of 5% had a better predictive value compared with that of 2%.
© 2016 Chinese Medical Association Shanghai Branch, Chinese Society of Gastroenterology, Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine and John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  Endoscopic ultrasound-guided fine needle aspiration; Ki-67; meta-analysis; neoplasm grading; neuroendocrine tumor; pancreatic neoplasms

Mesh:

Substances:

Year:  2016        PMID: 26713749     DOI: 10.1111/1751-2980.12310

Source DB:  PubMed          Journal:  J Dig Dis        ISSN: 1751-2972            Impact factor:   2.325


  7 in total

Review 1.  Fit-for-Purpose Immunohistochemical Biomarkers.

Authors:  Emina Emilia Torlakovic
Journal:  Endocr Pathol       Date:  2018-06       Impact factor: 3.943

2.  A Novel Validated Recurrence Risk Score to Guide a Pragmatic Surveillance Strategy After Resection of Pancreatic Neuroendocrine Tumors: An International Study of 1006 Patients.

Authors:  Mohammad Y Zaidi; Alexandra G Lopez-Aguiar; Jeffrey M Switchenko; Joseph Lipscomb; Valentina Andreasi; Stefano Partelli; Adriana C Gamboa; Rachel M Lee; George A Poultsides; Mary Dillhoff; Flavio G Rocha; Kamran Idrees; Clifford S Cho; Sharon M Weber; Ryan C Fields; Charles A Staley; Massimo Falconi; Shishir K Maithel
Journal:  Ann Surg       Date:  2019-09       Impact factor: 12.969

Review 3.  Imaging of pancreatic neuroendocrine tumors: recent advances, current status, and controversies.

Authors:  Lingaku Lee; Tetsuhide Ito; Robert T Jensen
Journal:  Expert Rev Anticancer Ther       Date:  2018-07-17       Impact factor: 4.512

4.  Can histogram analysis of MR images predict aggressiveness in pancreatic neuroendocrine tumors?

Authors:  Riccardo De Robertis; Bogdan Maris; Nicolò Cardobi; Paolo Tinazzi Martini; Stefano Gobbo; Paola Capelli; Silvia Ortolani; Sara Cingarlini; Salvatore Paiella; Luca Landoni; Giovanni Butturini; Paolo Regi; Aldo Scarpa; Giampaolo Tortora; Mirko D'Onofrio
Journal:  Eur Radiol       Date:  2018-01-19       Impact factor: 5.315

Review 5.  Pancreatic adenocarcinoma and pancreatic high-grade neuroendocrine carcinoma: two sides of the moon.

Authors:  Anna La Salvia; Irene Persano; Elena Parlagreco; Alessandro Audisio; Massimiliano Cani; Maria Pia Brizzi
Journal:  Med Oncol       Date:  2022-08-16       Impact factor: 3.738

Review 6.  [Grading of neuroendocrine tumors].

Authors:  W Saeger; P A Schnabel; P Komminoth
Journal:  Pathologe       Date:  2016-07       Impact factor: 1.011

7.  Endoscopic ultrasound-guided side-fenestrated needle biopsy sampling is sensitive for pancreatic neuroendocrine tumors but inadequate for tumor grading: a prospective study.

Authors:  Alexander Appelstrand; Fredrik Bergstedt; Anna-Karin Elf; Henrik Fagman; Per Hedenström
Journal:  Sci Rep       Date:  2022-04-08       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.